Stem Cell Banking

Global Stem Cell Banking Market to Reach US$15.6 Billion by 2030

The global market for Stem Cell Banking estimated at US$10.1 Billion in the year 2024, is expected to reach US$15.6 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Placental and Cord Blood Stem Cells, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$10.5 Billion by the end of the analysis period. Growth in the Adipose Tissue-Derived Stem Cells (ADSCS) segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.9 Billion While China is Forecast to Grow at 9.9% CAGR

The Stem Cell Banking market in the U.S. is estimated at US$3.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.9% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Stem Cell Banking Market - Key Trends & Drivers Summarized

Stem cell banking is a service that stores stem cells derived from amniotic fluid, umbilical cord blood, and other tissues at the time of childbirth for potential future medical use. Stem cells are highly valued in medical treatments because of their unique ability to differentiate into various types of cells, offering potential cures for a myriad of serious diseases, including certain types of cancer, blood disorders, and genetic diseases. The process of banking these cells involves the collection, processing, and cryopreservation of stem cells under stringent conditions to ensure their viability when needed for medical treatments. This proactive approach not only offers a sort of "biological insurance" for the child from whom the cells are collected but also for family members who might benefit from regenerative and personalized medicine facilitated by these stored cells.

In recent years, the technological advancements in cryopreservation and the expanding field of regenerative medicine have significantly boosted the stem cell banking industry. Improved cryogenic storage technologies have enhanced the efficiency and safety of long-term cell preservation, maintaining cell integrity over decades. Concurrently, ongoing medical research continues to broaden the scope of potential therapeutic applications for banked stem cells, which now include not only hematopoietic stem cell transplantations but also emerging treatments for conditions such as spinal cord injuries, Type 1 diabetes, and heart disease. Moreover, the ethical landscape around stem cell research has evolved, with more countries establishing clear regulations that support both the use and storage of stem cells, thereby promoting public trust and acceptance. These factors combine to provide a robust framework for the continued expansion and acceptance of stem cell banking services.

The growth in the stem cell banking market is driven by several factors, including increased public awareness and understanding of the potential therapeutic uses of stem cells, advancements in biomedical technologies, and the global rise in chronic diseases and genetic disorders. The market is further propelled by the growing number of births in developing countries, where parents are increasingly opting to store their newborns’ stem cells in light of improving economic conditions and healthcare infrastructures. Consumer behavior is also influenced by intense marketing campaigns and partnerships between hospitals and private banks, which help educate expecting parents about the benefits of stem cell storage. Additionally, the ongoing development of more sophisticated and targeted therapies in the field of personalized medicine necessitates a reliable supply of stem cells, thus ensuring continued demand for banking services. These drivers, along with supportive governmental health policies and a growing trend towards preventive healthcare measures, indicate a promising growth trajectory for the stem cell banking industry.

SCOPE OF STUDY:

The report analyzes the Stem Cell Banking market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Source (Placental and Cord Blood Stem Cells, Adipose Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem Cells (DPSCS), Other Stem Cell Sources); Service Type (Sample Preservation and Storage, Sample Analysis, Sample Processing, Sample Collection and Transportation); and Application (Personalized Banking Applications , Research Applications , Clinical Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 78 Featured) -

• FUJIFILM Holdings Corporation
• Reliance Life Sciences
• Cellavision AB
• Cryo-Cell International, Inc.
• Stem Cell Medicine Ltd.
• LifebankUSA
• LifeCell International Pvt., Ltd.
• CBR Systems, Inc.
• Medipost Co., Ltd.
• New England Cord Blood Bank, Inc.
• New York Blood Center
• Pharmicell Co., Ltd.
• CellResearch Corporation Pte., Ltd.
• AlphaCard
• FUJIFILM Cellular Dynamics, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.